What this test measures
HBV quantitative PCR (real-time PCR) measures the absolute amount of hepatitis B virus DNA in blood, reported in IU/mL (international units per millilitre). Detection limits are typically 10–20 IU/mL with linear measurement up to 10^8–10^9 IU/mL.
It directly quantifies viral replication and is the most important monitoring test in chronic hepatitis B. The viral load determines disease phase, treatment eligibility, treatment response, and infectivity (including mother-to-child transmission risk).
Why it matters
For the 40 million Indians with chronic HBV, the viral load number drives clinical decisions. AASLD and EASL guidelines define treatment thresholds in IU/mL — HBeAg-negative patients with > 2,000 IU/mL plus raised ALT typically need treatment; HBeAg-positive patients with > 20,000 IU/mL plus raised ALT also need treatment. Inactive carriers with low DNA (< 2,000 IU/mL) and normal ALT are monitored without treatment.
In pregnancy, viral load > 200,000 IU/mL (or > 10^5 copies/mL) in the third trimester triggers maternal antiviral therapy with tenofovir to reduce mother-to-child transmission below 5%. During treatment, quantitative HBV PCR is the standard response marker — undetectable viral load is the goal and is associated with reduced cirrhosis and HCC risk.
How to prepare
No fasting required. The test uses serum or plasma. Bring prior HBV reports (HBsAg, HBeAg, anti-HBe, ALT, prior viral loads if any) for trend interpretation.
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| HBV DNA Quantitative (IU/mL (log10 IU/mL))[1][2] | Treatment-naïve: < 20 IU/mL (below detection) | < 20 IU/mL (undetectable) — in untreated patients, suggests inactive carrier phase or resolved infection. In treated patients, indicates virological suppression — the treatment goal. | > 2,000 IU/mL — significant active replication. > 20,000 IU/mL — high replication, common in HBeAg-positive patients. > 200,000 IU/mL — very high, increases mother-to-child transmission risk and may warrant treatment intensification. |
HBV viral load thresholds for treatment decisions (AASLD/EASL)
| Phase / Scenario | HBV DNA Threshold | Action |
|---|---|---|
| Inactive carrier | < 2,000 IU/mL + normal ALT | Monitor every 6–12 months |
| HBeAg-negative chronic hepatitis | > 2,000 IU/mL + raised ALT | Treat with tenofovir/entecavir |
| HBeAg-positive chronic hepatitis | > 20,000 IU/mL + raised ALT | Treat with tenofovir/entecavir |
| Pregnancy — 3rd trimester | > 200,000 IU/mL | Maternal tenofovir to prevent transmission |
| On treatment — virological response | Undetectable | Continue, monitor every 3–6 months |
| Cirrhosis with any detectable DNA | Any detectable | Treat regardless of ALT |
Frequently asked questions
What does the HBV DNA result in IU/mL mean?
It is the number of international units of HBV DNA per millilitre of blood — a direct measure of how much virus is circulating. Higher values mean more active replication and greater infectivity.
My HBV DNA is undetectable. Am I cured?
Undetectable HBV DNA is the treatment goal but is not a cure. HBsAg loss (functional cure) is the ultimate aim and happens slowly. Continue your antivirals as prescribed.
I am pregnant — why is HBV viral load important?
Mother-to-child transmission risk rises sharply with viral load > 200,000 IU/mL. Maternal antiviral therapy with tenofovir in the third trimester reduces transmission to under 5% when combined with timely birth-dose vaccine and immunoglobulin for the baby.
How often should HBV DNA be tested?
In inactive carriers, every 6–12 months along with HBsAg and ALT. On antiviral therapy, every 3–6 months until undetectable, then every 6 months.
What if my HBV DNA rises during treatment?
Virological breakthrough (rise after suppression) can mean non-adherence to medication, drug resistance, or other factors. Discuss with your hepatologist — adherence check and possible drug switch may be needed.
Can quantitative HBV PCR be used for diagnosis?
Yes — but HBsAg is the screening test. HBV DNA quantitative is added after a positive HBsAg for staging and treatment decisions.
Is the test affordable in India?
Many NABL-accredited labs offer HBV quantitative PCR. NACO India provides free HBV DNA testing and antiviral treatment under the National Viral Hepatitis Control Programme for eligible patients.
Related Hepatitis tests
Tests commonly ordered alongside HEPATITIS B VIRUS (HBV) QUANTITATIVE PCR, or that help interpret an unexpected result.
Sources & references
- AASLD HBV Guidance 2018 · accessed 2026-05-30T00:00:00.000Z
- EASL 2017 CPG on HBV · accessed 2026-05-30T00:00:00.000Z
- CDC — Hepatitis B · accessed 2026-05-30T00:00:00.000Z
- WHO — Hepatitis B Fact Sheet · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your HEPATITIS B VIRUS (HBV) QUANTITATIVE PCR test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book HEPATITIS B VIRUS (HBV) QUANTITATIVE PCR now